A PDE model for imatinib-treated chronic myelogenous leukemia
From MaRDI portal
Publication:954304
DOI10.1007/s11538-008-9336-zzbMath1149.92018OpenAlexW2096698447WikidataQ46457933 ScholiaQ46457933MaRDI QIDQ954304
Doron Levy, Peter S. Kim, Peter P. Lee
Publication date: 10 November 2008
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-008-9336-z
PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Discrete version of topics in analysis (39A12)
Related Items (11)
Long-term treatment effects in chronic myeloid leukemia ⋮ Stability analysis of a simplified yet complete model for chronic myelogenous leukemia ⋮ Control of a consumer‐resource agent‐based model using partial differential equation approximation ⋮ Global dynamics of healthy and cancer cells competing in the hematopoietic system ⋮ On the global dynamics of a chronic myelogenous leukemia model ⋮ Controlled stochastic partial differential equations for rabbits on a grassland ⋮ Solutions of differential-difference equations arising from mathematical models of granulocytopoiesis ⋮ An ``age-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia ⋮ Mathematical analysis and global dynamics for a time-delayed Chronic Myeloid Leukemia model with treatment ⋮ Mathematical models of leukaemia and its treatment: a review ⋮ Optimal harvesting for a predator-prey agent-based model using difference equations
Cites Work
This page was built for publication: A PDE model for imatinib-treated chronic myelogenous leukemia
